Elgan Hopes Perseverance With Enteral Insulin For Preterm Infants Will Pay Off
Executive Summary
The product improved GI function and reduced related complications, including life-threatening events, in a Phase III study despite an initial futility analysis. An exec stayed confident, acquired the product and plans to initiate a confirmatory trial.